

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 4.85476030 |
| 2 | formation of translation preinitiation complex (GO:0001731) | 4.77977107 |
| 3 | nucleobase biosynthetic process (GO:0046112) | 4.69495602 |
| 4 | DNA deamination (GO:0045006) | 4.56702770 |
| 5 | ribosome assembly (GO:0042255) | 4.52437043 |
| 6 | maturation of SSU-rRNA (GO:0030490) | 4.48430479 |
| 7 | folic acid metabolic process (GO:0046655) | 4.41574053 |
| 8 | macromolecular complex disassembly (GO:0032984) | 4.23144508 |
| 9 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.13248732 |
| 10 | ribosome biogenesis (GO:0042254) | 4.09612456 |
| 11 | proteasome assembly (GO:0043248) | 4.07634838 |
| 12 | ribosomal large subunit biogenesis (GO:0042273) | 3.99868008 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 3.93171882 |
| 14 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.90879727 |
| 15 | viral transcription (GO:0019083) | 3.88041507 |
| 16 | protein targeting to membrane (GO:0006612) | 3.86683772 |
| 17 | translational termination (GO:0006415) | 3.82938199 |
| 18 | translational initiation (GO:0006413) | 3.78529754 |
| 19 | ribosomal small subunit biogenesis (GO:0042274) | 3.75725956 |
| 20 | mitotic metaphase plate congression (GO:0007080) | 3.69804145 |
| 21 | glycine metabolic process (GO:0006544) | 3.63385926 |
| 22 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.60976142 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.58141277 |
| 24 | translational elongation (GO:0006414) | 3.57496366 |
| 25 | DNA replication checkpoint (GO:0000076) | 3.55746119 |
| 26 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.53651042 |
| 27 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.51358528 |
| 28 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.48335112 |
| 29 | DNA replication initiation (GO:0006270) | 3.46609763 |
| 30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.45309933 |
| 31 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.43544008 |
| 32 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.43432382 |
| 33 | rRNA modification (GO:0000154) | 3.42529322 |
| 34 | DNA strand elongation (GO:0022616) | 3.41607060 |
| 35 | rRNA processing (GO:0006364) | 3.40921042 |
| 36 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.39013740 |
| 37 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.37695818 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.33234248 |
| 39 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.33103892 |
| 40 | deoxyribonucleotide catabolic process (GO:0009264) | 3.31751566 |
| 41 | rRNA metabolic process (GO:0016072) | 3.30763724 |
| 42 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.24727460 |
| 43 | mRNA catabolic process (GO:0006402) | 3.24496762 |
| 44 | folic acid transport (GO:0015884) | 3.23246875 |
| 45 | spliceosomal snRNP assembly (GO:0000387) | 3.21848620 |
| 46 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.21162848 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.19050526 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.19050526 |
| 49 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.16939899 |
| 50 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.15467506 |
| 51 | protein localization to kinetochore (GO:0034501) | 3.11811225 |
| 52 | deoxyribose phosphate catabolic process (GO:0046386) | 3.08851295 |
| 53 | termination of RNA polymerase III transcription (GO:0006386) | 3.08825002 |
| 54 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08825002 |
| 55 | protein targeting to ER (GO:0045047) | 3.07725848 |
| 56 | regulation of translation in response to stress (GO:0043555) | 3.06546725 |
| 57 | translation (GO:0006412) | 3.06176829 |
| 58 | cotranslational protein targeting to membrane (GO:0006613) | 3.05728785 |
| 59 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.05171278 |
| 60 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.05171278 |
| 61 | L-methionine salvage (GO:0071267) | 3.04884963 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 3.04884963 |
| 63 | amino acid salvage (GO:0043102) | 3.04884963 |
| 64 | regulation of spindle organization (GO:0090224) | 3.04789862 |
| 65 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.03313562 |
| 66 | pentose metabolic process (GO:0019321) | 3.02704287 |
| 67 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01852280 |
| 68 | nucleotide salvage (GO:0043173) | 3.01661378 |
| 69 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.00657321 |
| 70 | RNA catabolic process (GO:0006401) | 2.99921390 |
| 71 | positive regulation of ligase activity (GO:0051351) | 2.99029082 |
| 72 | mitotic nuclear envelope disassembly (GO:0007077) | 2.98612284 |
| 73 | protein maturation by protein folding (GO:0022417) | 2.98526477 |
| 74 | chaperone-mediated protein transport (GO:0072321) | 2.98222413 |
| 75 | viral life cycle (GO:0019058) | 2.98128744 |
| 76 | pyrimidine nucleoside salvage (GO:0043097) | 2.97250073 |
| 77 | pyrimidine-containing compound salvage (GO:0008655) | 2.97250073 |
| 78 | ATP synthesis coupled proton transport (GO:0015986) | 2.97121092 |
| 79 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.97121092 |
| 80 | viral protein processing (GO:0019082) | 2.97055721 |
| 81 | base-excision repair, AP site formation (GO:0006285) | 2.96799851 |
| 82 | immunoglobulin mediated immune response (GO:0016064) | 2.95950785 |
| 83 | IMP biosynthetic process (GO:0006188) | 2.95832132 |
| 84 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.95691121 |
| 85 | cellular protein complex disassembly (GO:0043624) | 2.95288778 |
| 86 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.95134480 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.95134480 |
| 88 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.94796257 |
| 89 | protein localization to endoplasmic reticulum (GO:0070972) | 2.94400644 |
| 90 | protein targeting to mitochondrion (GO:0006626) | 2.93105375 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 2.92998821 |
| 92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92753134 |
| 93 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92712545 |
| 94 | modulation by symbiont of host defense response (GO:0052031) | 2.92712545 |
| 95 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92712545 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92712545 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92712545 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 2.92712545 |
| 99 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91587240 |
| 100 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91587240 |
| 101 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91587240 |
| 102 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90905093 |
| 103 | DNA unwinding involved in DNA replication (GO:0006268) | 2.90257623 |
| 104 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89841870 |
| 105 | cellular component biogenesis (GO:0044085) | 2.89727895 |
| 106 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.89047367 |
| 107 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.89047367 |
| 108 | L-serine metabolic process (GO:0006563) | 2.88986015 |
| 109 | regulation of translational termination (GO:0006449) | 2.84878888 |
| 110 | metaphase plate congression (GO:0051310) | 2.84538081 |
| 111 | establishment of protein localization to membrane (GO:0090150) | 2.83835589 |
| 112 | telomere maintenance via recombination (GO:0000722) | 2.80454837 |
| 113 | pseudouridine synthesis (GO:0001522) | 2.80427307 |
| 114 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.79927772 |
| 115 | transcription from RNA polymerase I promoter (GO:0006360) | 2.79443641 |
| 116 | negative regulation of translational initiation (GO:0045947) | 2.79243439 |
| 117 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.79025554 |
| 118 | activation of MAPKKK activity (GO:0000185) | 2.75812806 |
| 119 | establishment of protein localization to mitochondrion (GO:0072655) | 2.75768577 |
| 120 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.75266216 |
| 121 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.74391004 |
| 122 | cell cycle G1/S phase transition (GO:0044843) | 2.74391004 |
| 123 | metallo-sulfur cluster assembly (GO:0031163) | 2.73353347 |
| 124 | iron-sulfur cluster assembly (GO:0016226) | 2.73353347 |
| 125 | protein localization to chromosome, centromeric region (GO:0071459) | 2.73288623 |
| 126 | membrane disassembly (GO:0030397) | 2.73114753 |
| 127 | nuclear envelope disassembly (GO:0051081) | 2.73114753 |
| 128 | methionine biosynthetic process (GO:0009086) | 2.72769453 |
| 129 | serine family amino acid metabolic process (GO:0009069) | 2.71870109 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.71342536 |
| 131 | respiratory electron transport chain (GO:0022904) | 2.71016921 |
| 132 | termination of RNA polymerase I transcription (GO:0006363) | 2.69830241 |
| 133 | blastocyst development (GO:0001824) | 2.69531841 |
| 134 | protein complex disassembly (GO:0043241) | 2.69370734 |
| 135 | serine family amino acid catabolic process (GO:0009071) | 2.69114457 |
| 136 | regulation of superoxide anion generation (GO:0032928) | 2.68785519 |
| 137 | regulation of ligase activity (GO:0051340) | 2.67647022 |
| 138 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.66792188 |
| 139 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.66554174 |
| 140 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.66414151 |
| 141 | IMP metabolic process (GO:0046040) | 2.66165497 |
| 142 | folic acid-containing compound metabolic process (GO:0006760) | 2.65894884 |
| 143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.65424879 |
| 144 | sulfur amino acid biosynthetic process (GO:0000097) | 2.63943820 |
| 145 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63657654 |
| 146 | negative regulation of cell killing (GO:0031342) | 2.63191239 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63191239 |
| 148 | positive thymic T cell selection (GO:0045059) | 2.62739688 |
| 149 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.62189808 |
| 150 | protein targeting (GO:0006605) | 2.61523205 |
| 151 | electron transport chain (GO:0022900) | 2.61129487 |
| 152 | modulation by virus of host process (GO:0019054) | 2.60892080 |
| 153 | pentose-phosphate shunt (GO:0006098) | 2.58730604 |
| 154 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.56544719 |
| 155 | oxidative phosphorylation (GO:0006119) | 2.55609192 |
| 156 | positive regulation of B cell differentiation (GO:0045579) | 2.53488681 |
| 157 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.52097897 |
| 158 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.51382413 |
| 159 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.51195114 |
| 160 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.49725529 |
| 161 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.49725529 |
| 162 | protein localization to mitochondrion (GO:0070585) | 2.48311747 |
| 163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46171129 |
| 164 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.45593845 |
| 165 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.43792128 |
| 166 | establishment of mitochondrion localization (GO:0051654) | 2.43460285 |
| 167 | response to peptidoglycan (GO:0032494) | 2.43087005 |
| 168 | positive regulation of T cell apoptotic process (GO:0070234) | 2.42650240 |
| 169 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.41878514 |
| 170 | mitochondrion transport along microtubule (GO:0047497) | 2.41878514 |
| 171 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.41146318 |
| 172 | neutrophil activation involved in immune response (GO:0002283) | 2.39600431 |
| 173 | protein insertion into membrane (GO:0051205) | 2.38439724 |
| 174 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.38181781 |
| 175 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.37139259 |
| 176 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37022779 |
| 177 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35930535 |
| 178 | heme biosynthetic process (GO:0006783) | 2.34818407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.89445697 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.84032202 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.66392019 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89980957 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.84866995 |
| 6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.81802674 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.81342194 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.71449961 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69395148 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.68515409 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.67860256 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.64740314 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.63146070 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.53573123 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.40174857 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26891652 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21559836 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.16657071 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.15278427 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.10615434 |
| 21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05484264 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.98036115 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96014957 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95642375 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87281063 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.82252735 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81578907 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.80510490 |
| 29 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.77106514 |
| 30 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76921608 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74945967 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.73095844 |
| 33 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72008319 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67082016 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66547068 |
| 36 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.66360907 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63440041 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62849305 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61618184 |
| 40 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61178860 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61029761 |
| 42 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59662097 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.58370210 |
| 44 | * MAF_26560356_Chip-Seq_TH2_Human | 1.57601422 |
| 45 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.54247559 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.53409822 |
| 47 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.52011842 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50589376 |
| 49 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.49426941 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48122196 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47705857 |
| 52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47012921 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46535729 |
| 54 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45877003 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.44690801 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.44491860 |
| 57 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44170762 |
| 58 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43717900 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.43629933 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40936577 |
| 61 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.37768136 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37709281 |
| 63 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37221843 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36363689 |
| 65 | * P68_20966046_ChIP-Seq_HELA_Human | 1.36077835 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35829122 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34103772 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.33568940 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33439726 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33398553 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32253374 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32076180 |
| 73 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.31935100 |
| 74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.31858915 |
| 75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31598653 |
| 76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30734710 |
| 77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29799435 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29745128 |
| 79 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29717111 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28604648 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26096488 |
| 82 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26040729 |
| 83 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25769924 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24860996 |
| 85 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.24190651 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23947375 |
| 87 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23234475 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22791516 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21317619 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21122219 |
| 91 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18591207 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18504339 |
| 93 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18501132 |
| 94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.17846947 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16883181 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16778514 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16450128 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16390965 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16239458 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15839423 |
| 101 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.15751556 |
| 102 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15620676 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15491725 |
| 104 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15030392 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13822139 |
| 106 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13753415 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12786548 |
| 108 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.12175723 |
| 109 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.11873926 |
| 110 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10148325 |
| 111 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10126883 |
| 112 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10027819 |
| 113 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09569202 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09416054 |
| 115 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08510393 |
| 116 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08206042 |
| 117 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07376073 |
| 118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06441216 |
| 119 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05877992 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05745393 |
| 121 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04807796 |
| 122 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04807796 |
| 123 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04807796 |
| 124 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04762170 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04234420 |
| 126 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01935493 |
| 127 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01676850 |
| 128 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01369663 |
| 129 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.01033853 |
| 130 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00922459 |
| 131 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00802176 |
| 132 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00464026 |
| 133 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00236622 |
| 134 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99914043 |
| 135 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99403806 |
| 136 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99387847 |
| 137 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98903793 |
| 138 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98520177 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98194181 |
| 140 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95602524 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95171286 |
| 142 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94007103 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93365384 |
| 144 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92630637 |
| 145 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92144180 |
| 146 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91875404 |
| 147 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.90060863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.87999539 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.73917934 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.70060710 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.42455749 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.42428043 |
| 6 | MP0003303_peritoneal_inflammation | 3.35053583 |
| 7 | MP0009840_abnormal_foam_cell | 3.29925287 |
| 8 | MP0003077_abnormal_cell_cycle | 3.00888831 |
| 9 | MP0003436_decreased_susceptibility_to | 2.87089338 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.85839635 |
| 11 | MP0005671_abnormal_response_to | 2.59363857 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.35062170 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.32182819 |
| 14 | MP0003718_maternal_effect | 2.31690577 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.27967749 |
| 16 | MP0009785_altered_susceptibility_to | 2.27745704 |
| 17 | MP0005025_abnormal_response_to | 2.22262181 |
| 18 | MP0001800_abnormal_humoral_immune | 2.20587012 |
| 19 | MP0001790_abnormal_immune_system | 2.18060566 |
| 20 | MP0005387_immune_system_phenotype | 2.18060566 |
| 21 | MP0001730_embryonic_growth_arrest | 2.14506096 |
| 22 | MP0002723_abnormal_immune_serum | 2.07641035 |
| 23 | MP0008058_abnormal_DNA_repair | 2.03001049 |
| 24 | MP0008932_abnormal_embryonic_tissue | 2.02890955 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.00750361 |
| 26 | MP0001819_abnormal_immune_cell | 1.98791098 |
| 27 | MP0003186_abnormal_redox_activity | 1.97950252 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.97192287 |
| 29 | MP0004510_myositis | 1.97009155 |
| 30 | MP0008057_abnormal_DNA_replication | 1.93327356 |
| 31 | MP0000685_abnormal_immune_system | 1.90032890 |
| 32 | MP0002822_catalepsy | 1.88877300 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.87249968 |
| 34 | MP0002419_abnormal_innate_immunity | 1.85628323 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.85265153 |
| 36 | MP0003786_premature_aging | 1.76968915 |
| 37 | MP0002398_abnormal_bone_marrow | 1.71978691 |
| 38 | MP0008260_abnormal_autophagy | 1.65434163 |
| 39 | MP0000350_abnormal_cell_proliferation | 1.65240505 |
| 40 | MP0000716_abnormal_immune_system | 1.64940042 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.63527857 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.58384307 |
| 43 | MP0001672_abnormal_embryogenesis/_devel | 1.57103652 |
| 44 | MP0005380_embryogenesis_phenotype | 1.57103652 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.56548017 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.55114191 |
| 47 | MP0003123_paternal_imprinting | 1.52137342 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.50945409 |
| 49 | MP0002429_abnormal_blood_cell | 1.48878429 |
| 50 | MP0010307_abnormal_tumor_latency | 1.48563773 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.48499218 |
| 52 | MP0000343_altered_response_to | 1.46243895 |
| 53 | MP0001697_abnormal_embryo_size | 1.45641580 |
| 54 | MP0002080_prenatal_lethality | 1.44445358 |
| 55 | MP0003984_embryonic_growth_retardation | 1.43954687 |
| 56 | MP0002163_abnormal_gland_morphology | 1.43202035 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.42762219 |
| 58 | MP0002088_abnormal_embryonic_growth/wei | 1.41789882 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.39922219 |
| 60 | MP0006082_CNS_inflammation | 1.36652760 |
| 61 | MP0003567_abnormal_fetal_cardiomyocyte | 1.35662190 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.34773227 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.34403706 |
| 64 | MP0005360_urolithiasis | 1.33813660 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.33742380 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.32503820 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.30996263 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.30996263 |
| 69 | MP0005332_abnormal_amino_acid | 1.30800417 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.30608154 |
| 71 | MP0003724_increased_susceptibility_to | 1.29782953 |
| 72 | MP0005451_abnormal_body_composition | 1.27434371 |
| 73 | MP0000490_abnormal_crypts_of | 1.26588278 |
| 74 | MP0000358_abnormal_cell_content/ | 1.25753551 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 1.25455815 |
| 76 | MP0000750_abnormal_muscle_regeneration | 1.24979450 |
| 77 | MP0002086_abnormal_extraembryonic_tissu | 1.24261332 |
| 78 | MP0005365_abnormal_bile_salt | 1.22413636 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.22076751 |
| 80 | MP0002405_respiratory_system_inflammati | 1.20973117 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.19940935 |
| 82 | MP0005058_abnormal_lysosome_morphology | 1.19551283 |
| 83 | MP0000313_abnormal_cell_death | 1.17514248 |
| 84 | MP0002019_abnormal_tumor_incidence | 1.17058639 |
| 85 | MP0002085_abnormal_embryonic_tissue | 1.16041245 |
| 86 | MP0003172_abnormal_lysosome_physiology | 1.14270521 |
| 87 | MP0008469_abnormal_protein_level | 1.11949517 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 1.10013848 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 1.09207679 |
| 90 | MP0009764_decreased_sensitivity_to | 1.08222730 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 1.07662902 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 1.06993591 |
| 93 | MP0002084_abnormal_developmental_patter | 1.06649812 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 1.06226741 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 1.05366530 |
| 96 | MP0000604_amyloidosis | 1.01992545 |
| 97 | MP0004381_abnormal_hair_follicle | 1.01516340 |
| 98 | MP0004858_abnormal_nervous_system | 0.98895528 |
| 99 | MP0000609_abnormal_liver_physiology | 0.98020403 |
| 100 | MP0005023_abnormal_wound_healing | 0.96216689 |
| 101 | MP0002132_abnormal_respiratory_system | 0.95951271 |
| 102 | MP0008995_early_reproductive_senescence | 0.95049772 |
| 103 | MP0000598_abnormal_liver_morphology | 0.94662031 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.94605728 |
| 105 | MP0009278_abnormal_bone_marrow | 0.94185265 |
| 106 | MP0002269_muscular_atrophy | 0.93630980 |
| 107 | MP0005395_other_phenotype | 0.92172529 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.89899037 |
| 109 | MP0005670_abnormal_white_adipose | 0.89005442 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.88327192 |
| 111 | MP0004084_abnormal_cardiac_muscle | 0.88081573 |
| 112 | MP0002653_abnormal_ependyma_morphology | 0.87030195 |
| 113 | MP0003075_altered_response_to | 0.86887206 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.86828564 |
| 115 | MP0004947_skin_inflammation | 0.86799144 |
| 116 | MP0003866_abnormal_defecation | 0.86492329 |
| 117 | MP0010030_abnormal_orbit_morphology | 0.86147849 |
| 118 | MP0003878_abnormal_ear_physiology | 0.86122298 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.86122298 |
| 120 | MP0001661_extended_life_span | 0.86034818 |
| 121 | MP0003329_amyloid_beta_deposits | 0.85871446 |
| 122 | MP0009053_abnormal_anal_canal | 0.84841895 |
| 123 | MP0003315_abnormal_perineum_morphology | 0.84762455 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.84694732 |
| 125 | MP0009672_abnormal_birth_weight | 0.84451459 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.84052361 |
| 127 | MP0001764_abnormal_homeostasis | 0.83005841 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.81838257 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.81709924 |
| 130 | MP0001756_abnormal_urination | 0.78423276 |
| 131 | MP0001849_ear_inflammation | 0.77692619 |
| 132 | MP0001145_abnormal_male_reproductive | 0.76865228 |
| 133 | MP0003646_muscle_fatigue | 0.76330932 |
| 134 | MP0001905_abnormal_dopamine_level | 0.76254444 |
| 135 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76008288 |
| 136 | MP0004808_abnormal_hematopoietic_stem | 0.75793336 |
| 137 | MP0001293_anophthalmia | 0.75423490 |
| 138 | MP0000747_muscle_weakness | 0.74865978 |
| 139 | MP0000858_altered_metastatic_potential | 0.74241562 |
| 140 | MP0000537_abnormal_urethra_morphology | 0.74107435 |
| 141 | MP0002210_abnormal_sex_determination | 0.74008881 |
| 142 | MP0005330_cardiomyopathy | 0.73661044 |
| 143 | MP0002722_abnormal_immune_system | 0.73218026 |
| 144 | MP0005076_abnormal_cell_differentiation | 0.72741577 |
| 145 | MP0005501_abnormal_skin_physiology | 0.71424322 |
| 146 | MP0001663_abnormal_digestive_system | 0.71242474 |
| 147 | MP0001986_abnormal_taste_sensitivity | 0.71021761 |
| 148 | MP0005384_cellular_phenotype | 0.70997760 |
| 149 | MP0000689_abnormal_spleen_morphology | 0.70538861 |
| 150 | MP0003183_abnormal_peptide_metabolism | 0.69839768 |
| 151 | MP0002796_impaired_skin_barrier | 0.67974667 |
| 152 | MP0005621_abnormal_cell_physiology | 0.67519990 |
| 153 | MP0009763_increased_sensitivity_to | 0.67186401 |
| 154 | MP0005266_abnormal_metabolism | 0.67031878 |
| 155 | MP0001542_abnormal_bone_strength | 0.65479281 |
| 156 | MP0002332_abnormal_exercise_endurance | 0.64463388 |
| 157 | MP0003119_abnormal_digestive_system | 0.64126290 |
| 158 | MP0000477_abnormal_intestine_morphology | 0.63095238 |
| 159 | MP0005499_abnormal_olfactory_system | 0.62506090 |
| 160 | MP0005394_taste/olfaction_phenotype | 0.62506090 |
| 161 | MP0005423_abnormal_somatic_nervous | 0.62237940 |
| 162 | MP0005645_abnormal_hypothalamus_physiol | 0.61767234 |
| 163 | MP0006292_abnormal_olfactory_placode | 0.60075384 |
| 164 | MP0005166_decreased_susceptibility_to | 0.59985310 |
| 165 | MP0001853_heart_inflammation | 0.59922437 |
| 166 | MP0000733_abnormal_muscle_development | 0.59829550 |
| 167 | MP0000015_abnormal_ear_pigmentation | 0.58456474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Multiple enchondromatosis (HP:0005701) | 4.37625299 |
| 2 | Breast hypoplasia (HP:0003187) | 4.18820783 |
| 3 | Hyperglycinemia (HP:0002154) | 3.90462924 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.78976762 |
| 5 | Hyperglycinuria (HP:0003108) | 3.70883121 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.69855762 |
| 7 | Carpal bone hypoplasia (HP:0001498) | 3.69515368 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 3.64074390 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.60311643 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.55778673 |
| 11 | Rough bone trabeculation (HP:0100670) | 3.48757591 |
| 12 | Abnormal number of erythroid precursors (HP:0012131) | 3.47668778 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.44117905 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.39766609 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.33996196 |
| 16 | Mitochondrial inheritance (HP:0001427) | 3.33126268 |
| 17 | Progressive muscle weakness (HP:0003323) | 3.32640771 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27879524 |
| 19 | Obstructive lung disease (HP:0006536) | 3.27879524 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.21457716 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.21457716 |
| 22 | Oral leukoplakia (HP:0002745) | 3.20275061 |
| 23 | Increased muscle lipid content (HP:0009058) | 3.19469453 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.18665766 |
| 25 | Macrocytic anemia (HP:0001972) | 3.18056591 |
| 26 | Reticulocytopenia (HP:0001896) | 3.16173912 |
| 27 | Hepatocellular necrosis (HP:0001404) | 3.09665083 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.09065172 |
| 29 | Hypertensive crisis (HP:0100735) | 3.08801089 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.06472759 |
| 31 | Degeneration of anterior horn cells (HP:0002398) | 3.04876685 |
| 32 | Abnormality of the anterior horn cell (HP:0006802) | 3.04876685 |
| 33 | Recurrent abscess formation (HP:0002722) | 2.99435269 |
| 34 | Trismus (HP:0000211) | 2.98720083 |
| 35 | Acute encephalopathy (HP:0006846) | 2.95268407 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.94336634 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.94064575 |
| 38 | Increased CSF lactate (HP:0002490) | 2.80879254 |
| 39 | Premature ovarian failure (HP:0008209) | 2.78638202 |
| 40 | Microretrognathia (HP:0000308) | 2.76759340 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.76001240 |
| 42 | Respiratory difficulties (HP:0002880) | 2.73757388 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.73112915 |
| 44 | Patellar aplasia (HP:0006443) | 2.72664143 |
| 45 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.71704432 |
| 46 | Exercise intolerance (HP:0003546) | 2.69566725 |
| 47 | Impulsivity (HP:0100710) | 2.69017825 |
| 48 | Nausea (HP:0002018) | 2.68607139 |
| 49 | Meningitis (HP:0001287) | 2.66249390 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.63415012 |
| 51 | Megaloblastic anemia (HP:0001889) | 2.62217772 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.61335319 |
| 53 | Cholecystitis (HP:0001082) | 2.61335319 |
| 54 | Increased IgM level (HP:0003496) | 2.58958347 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.58063919 |
| 56 | Selective tooth agenesis (HP:0001592) | 2.57692187 |
| 57 | Abnormality of the umbilical cord (HP:0010881) | 2.57098771 |
| 58 | Ragged-red muscle fibers (HP:0003200) | 2.55992936 |
| 59 | Gout (HP:0001997) | 2.55870194 |
| 60 | Renal Fanconi syndrome (HP:0001994) | 2.55034499 |
| 61 | Secondary amenorrhea (HP:0000869) | 2.50982475 |
| 62 | Petechiae (HP:0000967) | 2.48558212 |
| 63 | Abnormal trabecular bone morphology (HP:0100671) | 2.48335813 |
| 64 | 3-Methylglutaconic aciduria (HP:0003535) | 2.45807917 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45200569 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45200569 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45200569 |
| 68 | Cellulitis (HP:0100658) | 2.44008596 |
| 69 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.43864174 |
| 70 | Ureteral duplication (HP:0000073) | 2.42488292 |
| 71 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39272689 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.38313163 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.37839017 |
| 74 | Death in infancy (HP:0001522) | 2.37461852 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.36278842 |
| 76 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.36069505 |
| 77 | Abnormal cartilage morphology (HP:0002763) | 2.35255805 |
| 78 | Lactic acidosis (HP:0003128) | 2.30362236 |
| 79 | Peripheral hypomyelination (HP:0007182) | 2.30216235 |
| 80 | Increased hepatocellular lipid droplets (HP:0006565) | 2.26513390 |
| 81 | Lymphopenia (HP:0001888) | 2.24051510 |
| 82 | Stomatitis (HP:0010280) | 2.23931861 |
| 83 | Hyperammonemia (HP:0001987) | 2.23325393 |
| 84 | Microvesicular hepatic steatosis (HP:0001414) | 2.21644080 |
| 85 | Pallor (HP:0000980) | 2.21350988 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20172185 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.20172185 |
| 88 | Sparse eyelashes (HP:0000653) | 2.18798473 |
| 89 | CNS demyelination (HP:0007305) | 2.18572124 |
| 90 | Neoplasm of the pancreas (HP:0002894) | 2.17444169 |
| 91 | Muscle fiber splitting (HP:0003555) | 2.16980585 |
| 92 | Personality changes (HP:0000751) | 2.15544649 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15399235 |
| 94 | Myopathic facies (HP:0002058) | 2.15398243 |
| 95 | Purpura (HP:0000979) | 2.14852347 |
| 96 | Colon cancer (HP:0003003) | 2.13704743 |
| 97 | Rhabdomyolysis (HP:0003201) | 2.10539609 |
| 98 | Dysphonia (HP:0001618) | 2.09717201 |
| 99 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.09676712 |
| 100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.09676712 |
| 101 | Areflexia of lower limbs (HP:0002522) | 2.09643316 |
| 102 | Urticaria (HP:0001025) | 2.09441643 |
| 103 | Progressive external ophthalmoplegia (HP:0000590) | 2.07313706 |
| 104 | Hypobetalipoproteinemia (HP:0003563) | 2.06870477 |
| 105 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06291701 |
| 106 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.05855971 |
| 107 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05396036 |
| 108 | Lethargy (HP:0001254) | 2.05371734 |
| 109 | Pustule (HP:0200039) | 2.04765490 |
| 110 | Vacuolated lymphocytes (HP:0001922) | 2.03328858 |
| 111 | Absent radius (HP:0003974) | 2.03251255 |
| 112 | IgM deficiency (HP:0002850) | 2.02571033 |
| 113 | Emotional lability (HP:0000712) | 2.02520840 |
| 114 | Thrombocytosis (HP:0001894) | 2.02298248 |
| 115 | Absent thumb (HP:0009777) | 2.01997029 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 2.00696996 |
| 117 | Ependymoma (HP:0002888) | 2.00629566 |
| 118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99107787 |
| 119 | Cerebral edema (HP:0002181) | 1.99058061 |
| 120 | Deep palmar crease (HP:0006191) | 1.98814911 |
| 121 | CNS hypomyelination (HP:0003429) | 1.98510602 |
| 122 | Respiratory failure (HP:0002878) | 1.97110588 |
| 123 | Seborrheic dermatitis (HP:0001051) | 1.95829737 |
| 124 | Muscle fiber atrophy (HP:0100295) | 1.95716315 |
| 125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94594478 |
| 126 | Difficulty climbing stairs (HP:0003551) | 1.94239750 |
| 127 | Exertional dyspnea (HP:0002875) | 1.93897118 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.93844413 |
| 129 | Recurrent fungal infections (HP:0002841) | 1.93251727 |
| 130 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92300151 |
| 131 | Recurrent viral infections (HP:0004429) | 1.90648514 |
| 132 | Abnormality of the motor neurons (HP:0002450) | 1.90425634 |
| 133 | Abnormal neuron morphology (HP:0012757) | 1.90425634 |
| 134 | Entropion (HP:0000621) | 1.89308165 |
| 135 | Encephalitis (HP:0002383) | 1.88679455 |
| 136 | Mutism (HP:0002300) | 1.88306667 |
| 137 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.87976460 |
| 138 | Axonal loss (HP:0003447) | 1.87695985 |
| 139 | Gastrointestinal inflammation (HP:0004386) | 1.84005636 |
| 140 | Hyperalaninemia (HP:0003348) | 1.83904876 |
| 141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83904876 |
| 142 | Abnormality of alanine metabolism (HP:0010916) | 1.83904876 |
| 143 | Aplasia involving forearm bones (HP:0009822) | 1.83127744 |
| 144 | Absent forearm bone (HP:0003953) | 1.83127744 |
| 145 | Migraine (HP:0002076) | 1.83125685 |
| 146 | Colitis (HP:0002583) | 1.82802011 |
| 147 | Aplastic anemia (HP:0001915) | 1.82450970 |
| 148 | Xanthomatosis (HP:0000991) | 1.81826483 |
| 149 | Recurrent skin infections (HP:0001581) | 1.81603526 |
| 150 | Hepatic necrosis (HP:0002605) | 1.81047831 |
| 151 | Poor head control (HP:0002421) | 1.80476884 |
| 152 | Squamous cell carcinoma (HP:0002860) | 1.80065326 |
| 153 | Increased serum lactate (HP:0002151) | 1.79634587 |
| 154 | Spastic diplegia (HP:0001264) | 1.79508239 |
| 155 | Disinhibition (HP:0000734) | 1.79266331 |
| 156 | Abnormality of reticulocytes (HP:0004312) | 1.77717875 |
| 157 | Hyperthyroidism (HP:0000836) | 1.77445380 |
| 158 | Myositis (HP:0100614) | 1.77188662 |
| 159 | Neuronal loss in central nervous system (HP:0002529) | 1.76656620 |
| 160 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.75745149 |
| 161 | Calcaneovalgus deformity (HP:0001848) | 1.75274371 |
| 162 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74304319 |
| 163 | Patent foramen ovale (HP:0001655) | 1.74072095 |
| 164 | Bone marrow hypocellularity (HP:0005528) | 1.72578118 |
| 165 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.72227857 |
| 166 | Polycythemia (HP:0001901) | 1.71642584 |
| 167 | Verrucae (HP:0200043) | 1.71557683 |
| 168 | Increased serum ferritin (HP:0003281) | 1.71206988 |
| 169 | Testicular atrophy (HP:0000029) | 1.71153247 |
| 170 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.70404348 |
| 171 | Spastic paraparesis (HP:0002313) | 1.70291711 |
| 172 | Muscle fibrillation (HP:0010546) | 1.70094921 |
| 173 | Deformed tarsal bones (HP:0008119) | 1.69943633 |
| 174 | Atrioventricular block (HP:0001678) | 1.69159782 |
| 175 | Meckel diverticulum (HP:0002245) | 1.66839164 |
| 176 | Abnormal hemoglobin (HP:0011902) | 1.66624205 |
| 177 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.65955161 |
| 178 | Premature graying of hair (HP:0002216) | 1.65432944 |
| 179 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.63060456 |
| 180 | Glossoptosis (HP:0000162) | 1.62438637 |
| 181 | Horseshoe kidney (HP:0000085) | 1.61194484 |
| 182 | Cellular immunodeficiency (HP:0005374) | 1.60699677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.09695858 |
| 2 | WEE1 | 4.04505531 |
| 3 | VRK2 | 3.73806780 |
| 4 | NME2 | 3.63360547 |
| 5 | CDK19 | 3.21565662 |
| 6 | EPHA2 | 2.98950729 |
| 7 | NEK2 | 2.61991983 |
| 8 | EIF2AK1 | 2.57221981 |
| 9 | BCKDK | 2.41139927 |
| 10 | SIK2 | 2.27457056 |
| 11 | NEK1 | 2.26118098 |
| 12 | STK16 | 2.24995666 |
| 13 | TESK2 | 2.13079824 |
| 14 | DYRK3 | 2.06189255 |
| 15 | TSSK6 | 2.05884797 |
| 16 | TTK | 2.04433144 |
| 17 | SIK3 | 1.91743166 |
| 18 | SMG1 | 1.85776301 |
| 19 | PLK4 | 1.80322403 |
| 20 | PRPF4B | 1.76518864 |
| 21 | CDC7 | 1.69987216 |
| 22 | PLK1 | 1.69000052 |
| 23 | SRPK1 | 1.64211498 |
| 24 | TBK1 | 1.62038307 |
| 25 | PIM2 | 1.57852062 |
| 26 | ACVR1B | 1.54585352 |
| 27 | BRSK2 | 1.53537381 |
| 28 | IRAK4 | 1.52321484 |
| 29 | RPS6KA4 | 1.47290459 |
| 30 | RIPK4 | 1.43588988 |
| 31 | RPS6KB2 | 1.43376535 |
| 32 | MAP3K8 | 1.38354287 |
| 33 | ZAK | 1.37744473 |
| 34 | EIF2AK3 | 1.35459534 |
| 35 | TRIB3 | 1.32816886 |
| 36 | CDK7 | 1.32782929 |
| 37 | AURKB | 1.31015665 |
| 38 | MOS | 1.28969266 |
| 39 | MAP3K11 | 1.22569807 |
| 40 | CDK4 | 1.22254893 |
| 41 | CSK | 1.18993857 |
| 42 | MARK3 | 1.17673087 |
| 43 | AURKA | 1.17539770 |
| 44 | PDK4 | 1.16654784 |
| 45 | PDK3 | 1.16654784 |
| 46 | PAK4 | 1.13104087 |
| 47 | AKT3 | 1.11962109 |
| 48 | TLK1 | 1.09794727 |
| 49 | TAOK1 | 1.09772203 |
| 50 | EPHB2 | 1.09083286 |
| 51 | KDR | 1.09026751 |
| 52 | LRRK2 | 1.08726406 |
| 53 | SIK1 | 1.04340657 |
| 54 | CHEK2 | 1.03620378 |
| 55 | STK10 | 1.03486437 |
| 56 | IKBKE | 1.03475216 |
| 57 | PKN2 | 0.94722189 |
| 58 | ICK | 0.94588242 |
| 59 | PIM1 | 0.93672979 |
| 60 | FES | 0.93569226 |
| 61 | JAK3 | 0.93395056 |
| 62 | MAP2K2 | 0.93393517 |
| 63 | BRSK1 | 0.93136170 |
| 64 | MATK | 0.93103497 |
| 65 | IRAK3 | 0.92011529 |
| 66 | STK4 | 0.91937960 |
| 67 | CSF1R | 0.90897288 |
| 68 | PLK3 | 0.90678139 |
| 69 | PINK1 | 0.88402769 |
| 70 | EEF2K | 0.87360344 |
| 71 | BRAF | 0.87293130 |
| 72 | BTK | 0.86748961 |
| 73 | MAP3K10 | 0.86084917 |
| 74 | ATR | 0.86047613 |
| 75 | PDK2 | 0.85045488 |
| 76 | ABL2 | 0.84399388 |
| 77 | ARAF | 0.82983253 |
| 78 | NME1 | 0.82408395 |
| 79 | MAP2K3 | 0.81623919 |
| 80 | SCYL2 | 0.80824550 |
| 81 | VRK1 | 0.79282559 |
| 82 | TNK2 | 0.79064802 |
| 83 | CLK1 | 0.78190060 |
| 84 | ERN1 | 0.78095245 |
| 85 | PAK1 | 0.78063637 |
| 86 | PASK | 0.76761356 |
| 87 | MAP3K13 | 0.76695157 |
| 88 | MAPKAPK3 | 0.76110422 |
| 89 | LIMK1 | 0.75973364 |
| 90 | FGR | 0.75481115 |
| 91 | ALK | 0.75476712 |
| 92 | SYK | 0.75074246 |
| 93 | STK38L | 0.74727486 |
| 94 | MARK2 | 0.73759179 |
| 95 | CHEK1 | 0.73560439 |
| 96 | MAP3K3 | 0.72348850 |
| 97 | LYN | 0.72002916 |
| 98 | STK3 | 0.71938334 |
| 99 | DAPK3 | 0.71073786 |
| 100 | LATS2 | 0.69388274 |
| 101 | PRKCI | 0.68533165 |
| 102 | TESK1 | 0.68226902 |
| 103 | CDK12 | 0.68031794 |
| 104 | FLT3 | 0.66758531 |
| 105 | TGFBR1 | 0.66104011 |
| 106 | CSNK2A2 | 0.63334667 |
| 107 | BMX | 0.61818585 |
| 108 | MKNK1 | 0.61611973 |
| 109 | CSNK2A1 | 0.61088933 |
| 110 | MAP4K1 | 0.60825622 |
| 111 | BLK | 0.60757979 |
| 112 | CDK11A | 0.60558144 |
| 113 | DAPK1 | 0.60252626 |
| 114 | RPS6KC1 | 0.55166118 |
| 115 | RPS6KL1 | 0.55166118 |
| 116 | PNCK | 0.55151920 |
| 117 | * CDK2 | 0.54573310 |
| 118 | MTOR | 0.53081195 |
| 119 | TYK2 | 0.51792001 |
| 120 | RPS6KA5 | 0.51529950 |
| 121 | ILK | 0.51352751 |
| 122 | IRAK2 | 0.50656530 |
| 123 | TTN | 0.50165785 |
| 124 | ZAP70 | 0.49585231 |
| 125 | MAPK12 | 0.49395300 |
| 126 | CDK6 | 0.48574168 |
| 127 | LCK | 0.48102505 |
| 128 | CDK14 | 0.47612577 |
| 129 | FGFR4 | 0.47290739 |
| 130 | CCNB1 | 0.46633116 |
| 131 | MAP4K2 | 0.43877993 |
| 132 | MAPK4 | 0.42978784 |
| 133 | AKT2 | 0.42729280 |
| 134 | TAOK2 | 0.41656395 |
| 135 | TXK | 0.41294952 |
| 136 | MAP3K1 | 0.40856807 |
| 137 | PBK | 0.39977467 |
| 138 | HCK | 0.39235249 |
| 139 | GRK6 | 0.39174019 |
| 140 | HIPK2 | 0.38747848 |
| 141 | CDK15 | 0.37625310 |
| 142 | MAPK11 | 0.37262436 |
| 143 | PRKCQ | 0.36588051 |
| 144 | CSNK1E | 0.36289930 |
| 145 | RPS6KA6 | 0.36057161 |
| 146 | DYRK2 | 0.35517381 |
| 147 | ITK | 0.35374533 |
| 148 | PRKD2 | 0.35285883 |
| 149 | PKN1 | 0.34945861 |
| 150 | IKBKB | 0.32962687 |
| 151 | ATM | 0.31279790 |
| 152 | DYRK1B | 0.31000357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.68175607 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.36543044 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.34732696 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.16331312 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.14996141 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.98466393 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.82567475 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.62198556 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.60080534 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.47934608 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.32485739 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.24214308 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.19245042 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.17084955 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.11398836 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.00760042 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.95942636 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.91341502 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88951856 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83472754 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.82948860 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82593699 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80767194 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.79868448 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.74965506 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.72955431 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.71982404 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.65416739 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61746275 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60482742 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59467440 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55490258 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.54434948 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52866102 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47514104 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46300816 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44217161 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41628567 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39585615 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35029614 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34128284 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31911915 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.30993171 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30787932 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30391387 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.26199037 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21076506 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.20517823 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19140437 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.16082590 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15279729 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14371704 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.12606339 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10117002 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09153956 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 1.08852776 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 1.07882381 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07643973 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06122694 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02902153 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01681926 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00991827 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00435214 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99997131 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.98826474 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95246471 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95101463 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94544377 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92752792 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92607102 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92484363 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91027727 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.90446138 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89658993 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89158853 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.88315492 |
| 77 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.87101593 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86601471 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84245242 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83374833 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83154877 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78929199 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78616966 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77851970 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76959865 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75100973 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74803557 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74601630 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74328047 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.73855728 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69592401 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68780435 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66379036 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66137363 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66033033 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65949963 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65911856 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.64533597 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64305972 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.62765766 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61325587 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60964371 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59680673 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58790442 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.56856586 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56094279 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55972283 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54185969 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51448221 |
| 110 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51181630 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50695804 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.50233817 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48097334 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.47262945 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45758573 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45451922 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45405527 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45018826 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44283419 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44072816 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.43659510 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43602601 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43188406 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43017757 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42887697 |
| 126 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40927613 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40104841 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39778775 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37405193 |
| 130 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36878649 |
| 131 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36791455 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.36671235 |
| 133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36563448 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36098748 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35849271 |
| 136 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34979643 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34512780 |
| 138 | Hepatitis B_Homo sapiens_hsa05161 | 0.34271566 |
| 139 | Protein export_Homo sapiens_hsa03060 | 0.34059535 |
| 140 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33321207 |
| 141 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32637359 |
| 142 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32337299 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32010432 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31044927 |
| 145 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29414616 |
| 146 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29405768 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28762001 |
| 148 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28498578 |
| 149 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28448405 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27072529 |
| 151 | Apoptosis_Homo sapiens_hsa04210 | 0.26971002 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.25590876 |
| 153 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24372722 |
| 154 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23857007 |
| 155 | Lysosome_Homo sapiens_hsa04142 | 0.23227924 |

